13-10-2026 06:36 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  About Us   Services             Trading   Depository    
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Share Holdings
Symbiotec Pharmalab Ltd.
 
BSE Code 544889
ISIN Demat INE899I01028
Book Value 0.00
NSE Code SYMBIOTEC
Dividend Yield % 0.00
Market Cap 70771.68
P/E 79.57
EPS 13.84
Face Value 2  
Description ( As On August 2026 )No. of ShareHoldersNo. of Shares% of SharesDemat
Promoter          
  Indian Promoter  9  21383823  33.28  21383823  
  Foreign Promoter          
  Total Promoter  9  21383823  33.28  21383823  
          
Non Promoter          
 Institutions          
  Mutual Funds / UTI  16  3558887  5.54  3558887  
  FI/Bank/Insurance  55  2417213  3.76  2417213  
  Govt          
  FII          
  Other  116  24522443  38.17  24522443  
  Total Institutions  187  30498543  47.47  30498543  
 Non-Institution          
  Bodies Corporate  72  65517  0.1  65517  
  Individuals          
  NRIs/OCBs  357  586927  0.91  586927  
  Others  427105  11721302  18.24  11721302  
  Total Non-Institution  427534  12373746  19.25  12373746  
Total Non Promoter  427721  42872289  66.72  42872289  
          
  Depository Receipts          
          
Grand Total  427730  64256112  100  64256112  
 
Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors
KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
Few Important Links: NSE | BSE | NSDL | CDSL | SEBI | MCX | NCDEX | FMC | RBI | AMFI | My Company GST Number | SCORES | DP 15 | BSE PLUS
Contact Us | Careers | Downloads | Notice |Margin Obligation Circular |Creating Investor | Policies| Details of KMPS | Public information for Investors
Circular | BOI UPI ID & QR Code | Research Analyst Certificate | Internal policy RA
SEBI Reg. No INZ000209538 Depository CDSL: IN-DP-15-2015 Research Reg. No.: INH000011219
© 2006 J G Shah Financial Consultants Pvt.Ltd. All rights reserved.
Designed || Developed & Content Powerd By Accord Fintech Pvt. Ltd.